Ferring Pharmaceuticals bolsters global gene therapy supply chain with European manufacturing facility

Contributed by: Business Wire

Logo

Tags

Research

Genetics

Clinical Trials

Stem Cells

Biotechnology

Physical Therapy

Health

Science

Oncology

Other Science

European Manufacturing Facility

More Like This

Ferring achieved record sales driven by Reproductive Medicine combined with the emergence of Adstiladrin

Ferring Japan announces PMDA Acceptance of NDA Filing for nadofaragene firadenovec

For the First Time, Ferring Reports Revenue of Over €2.5 Billion in 2025

Launch of two first-in-class medicines in 2023 marks start of exciting phase of growth for Ferring

PR Newswire associated0

Fennec Pharmaceuticals and Norgine Enter into Exclusive Licensing Agreement to Commercialize PEDMARQSI in Europe, Australia, and New Zealand

PR Newswire associated0

Apertura Gene Therapy and Viralgen Announce Strategic Collaboration to Manufacture TfR1 CapX, a Next-Generation Capsid for Gene Therapies Designed to Treat Central Nervous System Diseases

PR Newswire associated0

Norgine strengthens rare disease portfolio with acquisition of Theravia

Sangamo Therapeutics Announces U.S. FDA Alignment on Abbreviated Pathway to Potential Approval and EMA Prime Eligibility for ST-920 in Fabry Disease